Akademska digitalna zbirka SLovenije - logo
ALL libraries (COBIB.SI union bibliographic/catalogue database)
  • Continuous axial-flow left ventricular assist device (Jarvik 2000) maintains kidney and liver perfusion for up to 6 months
    Letsou, George V. ...
    Background: The Jarvik 2000 axial flow left ventricular assist device (LVAD), under development for the past decade, has the potential to support patients temporarily until cardiac transplantation or ... as a permanent circulatory support, without the size limitations of other implantable systems. Methods: To assess its ability to perfuse the kidneys and liver, we monitored renal andhepatic function in 10 patients who received the Jarvik 2000 LVAD as a bridge to transplantation. Left ventricular assistance was maintained for up to 214 days (> 6 months), and renal and hepatic function were monitored at least weekly. Results: Renal function before LVAD implantation in these patients was normal in 7 (creatinine, < 1.5) and moderately impaired in 3 (creatinine, 1.2 to 2.0). Hepatic function was normal in 7 patients before LVAD implantation (total bilirubin< 1.2; serum glutamic-oxaloacetic transaminase (SGOT), < 40; serum glutamic-pyruvic transaminase (SGPT), < 50) and normal at the time of transplantation in all 10 patients. Of the 3 patients with abnormal hepatic function before LVAD implantation, 1 patient had also had moderate renal dysfunction. CONCLUSIONS: Despite reduced pulsatility, the Jarvik 2000 LVAD improves or maintains excellent renal and hepatic function during periods of circulatory assistance in patients awaitingtransplantation.
    Source: The Annals of thoracic surgery. - ISSN 0003-4975 (Letn. 76, št. 4, 2003, str. 1167-1170)
    Type of material - article, component part
    Publish date - 2003
    Language - english
    COBISS.SI-ID - 24111577

source: The Annals of thoracic surgery. - ISSN 0003-4975 (Letn. 76, št. 4, 2003, str. 1167-1170)
loading ...
loading ...
loading ...